NCT03407001View on ClinicalTrials.gov

Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

September 15, 2020

Study Completion Date

September 15, 2020

Conditions
Cirrhosis
Interventions
PROCEDURE

Contrast-Enhanced Ultrasound

Undergo CEUS

DRUG

Sulfur Hexafluoride Lipid Microspheres

Given IV

PROCEDURE

Ultrasound

Undergo non-contrast US

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03407001 - Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis | Biotech Hunter | Biotech Hunter